Close Menu

Othman Laraki, the CEO and co-founder of Color Genomics, tells Barron's Penta that what his firm is doing differs from that of other genetic testing companies in that it is not following the direct-to-consumer model and offers a clinical product. As Penta notes, Color currently offers a saliva-based test of genetic variants linked to risk of cancers like breast, colon, and pancreatic cancer, as well as to heart disease and medication response.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers uncovered the HIV virus within a tissue sample collected in 1966, the Atlantic reports.

Nature News reports there are a handful of clinical trials underway to evaluate vaginal microbiome seeding of newborns born via caesarian section.

The Washington Post writes that humans may have contributed to the extinction of cave bears some 20,000 years ago.

In PLOS this week: gene variant may protect against trypanosomiasis, GLIS3 role in type 2 diabetes, and more.